Danilo Segovia

Patient-derived xenografts and in vitro model show rationale for imatinib mesylate repurposing in HEY1-NCoA2-driven mesenchymal chondrosarcoma

S. Lyons, Sania Jevtic, R. Sordella, 2021, Laboratory Investigation.